Back to top

Analyst Blog

McCormick & Company, Inc. (MKC - Analyst Report) is set to report fiscal third quarter 2013 results before the opening bell on Sep 26. Last quarter, this global leader in flavors posted in-line results. Let’s see how things are shaping up prior to the announcement.

Factors to Consider This Quarter

McCormick’s industrial business segment has been under pressure over the last few quarters due to the slowdown in demand from quick service restaurants, primarily in the U.S and Asia. In the U.S., quick service restaurant demand was soft due to focus on menu items not flavored by McCormick, while in Asia demand was adversely impacted by bird flu concerns in China. Also, the unfavorable mix of businesses affected industrial segment operating income in the quarter.

On the contrary, McCormick’s consumer business segment is doing well, driven by the recent acquisition of the Chinese broth maker Wuhan Asia-Pacific Condiments Co. Ltd. (“WAPC”) in Jun 2013. The WAPC acquisition has enhanced McCormick’s product portfolio in central China.

McCormick raised its sales projection for fiscal 2013 to include the impact of the acquisition. However, it has lowered its operating income growth rate and thereby earnings projection for fiscal 2013 to reflect the continued sluggishness in the industrial segment in the upcoming quarters.

We believe that the sluggish performance from the industrial business will take a toll in the third quarter as well. In addition, low disposable income of consumers and a high single-digit increase in raw material and packaging costs are expected to hurt margins and thereby its profitability. This along with currency headwinds and slow economic recovery in the U.S. is expected to more than offset the positive impact from acquisition in the third quarter.

Earnings Whispers

Our proven model does not conclusively show that McCormick is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1, #2 or #3 for this to happen. That is not the case here as shown below.

Positive Zacks ESP: The Most Accurate estimate stands at 79 cents while the Zacks Consensus Estimate is at 78 cents. That is a difference of +1.28%.

Zacks Rank #4 (Sell): We caution against stocks with Zacks Rank #4 and #5 (Sell rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions momentum.

Other Stocks to Consider

Here are some other companies in the consumer staple sector that can be considered as our model shows they have the right combination of elements to post an earnings beat this quarter:

Treehouse Foods Inc. (THS - Snapshot Report), Earnings ESP of +1.30% and a Zacks Rank #2 (Buy)

Hormel Foods Corp (HRL - Analyst Report), Earnings ESP of +1.85% and a Zacks Rank #3 (Hold)

Kellogg Co. (K - Analyst Report), Earnings ESP of +1.11% and a Zacks Rank #3.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
PLANAR SYST… PLNR 4.44 +5.21%
BITAUTO HOL… BITA 81.71 +5.12%
CTPARTNERS… CTP 16.66 +4.26%
CHINA BIOLO… CBPO 47.91 +3.30%
MALLINCKROD… MNK 72.94 +2.85%